Philadelphia Facilities Alert Due to Civil Unrest
See the latest Coronavirus Information including testing sites, visitation restrictions, appointments and scheduling, and more.
Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Recognized by America's Top Doctors, 2005 - 2018
Recognized by Best Doctors in America 2017 - 2018
Recognized in Philadelphia magazine's annual Top Docs issues, 2005 - 2020
Penn Presbyterian Medical Center
240 Medical Office Building
51 N. 39th Street
Philadelphia, PA 19104
A facility of Penn Presbyterian Medical Center
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Contrast Media Injury to the Kidney Cardiac – Renal Interactions
Rudnick MR., Goldfarb S.: Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. [Review] [31 refs] Reviews in Cardiovascular Medicine 4 Suppl 5 : S28-33,2003.
Wang A., Holcslaw T., Bashore TM., Freed MI., Miller D., Rudnick MR., Szerlip H., Thames MD., Davidson CJ., Shusterman N., Schwab SJ.: Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism.[see comment] Kidney International 57 (4): 1675-80,2000.
Berns JS., Rudnick MR., Cohen RM., Bower JD., Wood BC.: Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease Kidney International 56 (1): 253-60,1999.
Ermer JC., Boni JP., Cevallos WH., DeCleene S., Burghart P., Rudnick MR., Fruncillo RJ., Berns JS., Cohen RM.: Bromfenac disposition in patients with impaired kidney function Clinical Pharmacology & Therapeutics 61 (3): 312-8,1997.
Rudnick MR., Berns JS., Cohen RM., Goldfarb S.: Contrast media-associated nephrotoxicity. [Review] [150 refs] Seminars in Nephrology 17 (1): 15-26,1997.
Rudnick MR., Berns JS., Cohen RM., Goldfarb S.: Contrast media-associated nephrotoxicity. [Review] [83 refs] Current Opinion in Nephrology & Hypertension 5 (2): 127-33,1996.
Berns JS., Haghighat A., Staddon A., Cohen RM., Schmidt R., Fisher S., Rudnick MR., Tomaszewski JE.: Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients Cancer 76 (3): 497-500,1995.
Rudnick MR., Goldfarb S., Wexler L., Ludbrook PA., Murphy MJ., Halpern EF., Hill JA., Winniford M., Cohen MB., VanFossen DB.: Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study Kidney International 47 (1): 254-61,1995.
Revicki DA., Brown RE., Feeny DH., Henry D., Teehan BP., Rudnick MR., Benz RL.: Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients American Journal of Kidney Diseases 25 (4): 548-54,1995.
Roth D., Smith RD., Schulman G., Steinman TI., Hatch FE., Rudnick MR., Sloand JA., Freedman BI., Williams WW Jr., Shadur CA., et al.: Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients American Journal of Kidney Diseases 24 (5): 777-84,1994.
Presbyterian Medical Center39th and Market StreetsMedical Office BuildingSuite 240
Patient appointments: 800-789-7366